Tag: Competition and Markets Authority
Rule Britannia: Thanks to Brexit It Does… At Least in Antitrust
By Lawrence B. Landman*
Many observers were surprised when the United Kingdom’s Competition and Markets Authority (“CMA”) recently prohibited Microsoft’s proposed $69 billion acquisition of...
Brave New World?
The UK’s Competition and Markets Authority is expected soon to get new powers to regulate digital companies with Strategic Market Status (“SMS”). Once the...
UK Regulator Cracks Down On ‘Bundling’ Rules
The UK’s Competition and Markets Authority (CMA) this week announced that it has directed NatWest to issue refunds after it was found to have...
UK Looks Into Apple, Google’s Mobile Browser Dominance
Britain's competition watchdog said it was planning to investigate the market dominance of Apple and Google's mobile browsers, as well as the iPhone maker's restrictions...
Competition Issues in UK Grocery Retailing
Over the past 20 years, grocery retailing has probably been the sector most investigated by the UK competition authorities. Given that three quarters of...
UK Concerned Over Sony Music’s Purchase Of AWAL
Sony Music Entertainment's purchase of London-based independent record label AWAL has raised competition concerns as it may lead to worse terms for artists, a...
Open Banking, the UK Experience
The paper explains what open banking is, why the Competition and Markets Authority adopted it as a remedy and describes the arrangements the CMA...
UK Court Orders Disqualification Of Estate Agent Who Formed A Cartel
In the first contested case of its kind, the Competition and Markets Authority (CMA) has secured the disqualification of a director whose Somerset estate...
Medical Suppliers’ Merger Raises Antitrust Concerns In The UK
The Competition and Markets Authority (CMA) is concerned that, should the proposed £4.2 billion (US$5.2 billion) purchase by Stryker Corporation (Stryker) of Wright Medical...
UK: Anti-nausea drug faces price collusion allegations
Four pharmaceutical companies have been accused of colluding to artificially increase the price of a drug used to treat nausea and dizziness by almost...
